DISEASE:
| ALK | ALK |
| Transplantation | Transplantation |
CATEGORY:
| ALK Rearrangement and Lung Cancer | ALK Rearrangement and Lung Cancer |
| Diagnosis of ALK Rearrangement | Diagnosis of ALK Rearrangement |
| ALK gene fusions, crizotinib, and NSCLC | ALK gene fusions, crizotinib, and NSCLC |
SPEAKER:
| Susana R. Marino, MD, PhD, D (ABHI) | Susana R. Marino, MD, PhD, D (ABHI) |
| Robert Doebele | Robert Doebele |
| Marileila Varella-Garcia | Marileila Varella-Garcia |
| William Hildebrand, PhD | William Hildebrand, PhD |
| Mike Bunce, PhD | Mike Bunce, PhD |
EVENT:
| 2011 Association of Molecular Pathology Meeting | 2011 Association of Molecular Pathology Meeting |
| ASHI | ASHI |
Below you will find information that will help enhance your clinical and molecular laboratory knowledge. This section will provide presentations led by prominent physicians, laboratory leaders, subject matter experts, and Abbott scientific professionals that will provide insight on molecular diagnostic trends, genetic and biomarker innovations, medical discoveries, health technologies, and more.
| Disease | Title | Speaker | Event |
|
|
|
|
|
Developments for Lung Adenocarcinoma Patients: Targeting ALK Rearrangements
Program Learning Objectives:
- Learn about Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements in lung cancer
- Discuss new testing methods for ALK Gene Rearrangement in lung cancer
- Review guidelines for Xalkori® (crizotinib) and ALK testing relating to histology and timing of testing
- Identify the appropriate selection of patients for Xalkori® (crizotinib)
- Examine clinical trial results for Xalkori® (crizotinib) and overview of ongoing trials
| Presented by: | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|||||||||
Diagnosis of ALK Rearrangement by FISH in NSCLC
As presented at the 2011 Association of Molecular Pathology Meeting.
| Presented by: | |
|---|---|
| Marileila Varella-Garcia, PhD | |
| Professor of Medicine Education Program | |
| Leader, Cytogenetics Core Director | |
| University of Colorado, Denver | |
| School of Medicine , Division of Medical Oncology | |
New Technology Opportunities in Solid Organ
Transplant Testing
You will need to view all four modules to obtain 1.0 contact hours of P.A.C.E.® (Professional Acknowledgment for Continuing Education) credit in addition to completing the
Evaluation and Verification of Participation forms. These may be emailed to rebecca.schingel@remedica.com or faxed to 312-993-1522.
Module 1• Learning Objectives and Faculty Disclosures • Management of Highly Sensitized Kidney Transplant Patients in the Context of State-of- the-Art HLA Testing Technologies Presented by: Susana R. Marino, MD, PhD, D (ABHI) |
Module 3• Question and Answer Session (recorded at the 2011 Annual Meeting of The American Society for Histocompatibility and Immunogenetics, ASHI) • How to Obtain CE Credit |
Module 2Current Challenges and Developments in HLA Immunoassay Reagents Presented by: William Hildebrand, PhD |